Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.1 USD | -1.27% | +12.47% | +64.50% |
Apr. 01 | Solid Biosciences' SGT-003 Receives US FDA's Rare Pediatric Disease Label | MT |
Apr. 01 | Solid Biosciences Gets FDA Rare-Pediatric Designation for SGT-003 in Duchenne | DJ |
Financials (USD)
Sales 2024 * | 3.62M | Sales 2025 * | 4.94M | Capitalization | 382M |
---|---|---|---|---|---|
Net income 2024 * | -95M | Net income 2025 * | -120M | EV / Sales 2024 * | 64.1 x |
Net cash position 2024 * | 150M | Net cash position 2025 * | 67.4M | EV / Sales 2025 * | 63.7 x |
P/E ratio 2024 * |
-3.72
x | P/E ratio 2025 * |
-3.65
x | Employees | 88 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.97% |
Latest transcript on Solid Biosciences Inc.
1 day | -1.27% | ||
1 week | +12.47% | ||
Current month | +13.87% | ||
1 month | -18.42% | ||
3 months | +43.87% | ||
6 months | +255.63% | ||
Current year | +64.50% |
Managers | Title | Age | Since |
---|---|---|---|
Annie Ganot
FOU | Founder | - | 13-02-28 |
Ilan Ganot
FOU | Founder | 50 | 13-02-28 |
Alexander Cumbo
CEO | Chief Executive Officer | 53 | 22-09-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ian Smith
CHM | Chairman | 58 | 20-04-14 |
Martin Freed
BRD | Director/Board Member | 63 | 18-06-25 |
Raj Shah
BRD | Director/Board Member | 46 | 17-02-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 10.1 | -1.27% | 674,823 |
24-05-02 | 10.23 | +7.23% | 267,252 |
24-05-01 | 9.54 | +7.55% | 175,841 |
24-04-30 | 8.87 | +0.91% | 171,145 |
24-04-29 | 8.79 | -2.12% | 113,767 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+64.50% | 382M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- SLDB Stock